Comparaciones indirectas en los informes de evaluación de medicamentos en la web del grupo GENESIS de la SEFH

Ortega-Eslava, A. (Ana); Fraga-Fuentes, M.D. (M.D.); Puigventos, F. (Francesc); Santos-Ramos, B. (B.); Clopes-Estela, A. (A.); Vilanova-Bolto, M. (M.)

Otros títulos :

Indirect comparisons in drug assessment reports on the GENESIS group (SEFH) webpage

Autor(es):

Ortega-Eslava, A. (Ana)

Fraga-Fuentes, M.D. (M.D.)

Puigventos, F. (Francesc)

Santos-Ramos, B. (B.)

Clopes-Estela, A. (A.)

Vilanova-Bolto, M. (M.)

Palabras clave :

Indirect comparisons
Decision-making
Drug evaluation

Fecha de publicación :

2012

Editorial :

Elsevier

ISSN :

1130-6343

Cita:

Ortega Eslava A, Puigventos Latorre F, Santos-Ramos B, Calderon Hernanz B, Vilanova Bolto M, en representacion del Grupo de Evaluacion de Novedades, Estandarizacion e Investigacion en Seleccion de Medicamentos (GENESIS) de la Sociedad Española de Farmacia Hospitalaria (SEFH). Comparaciones indirectas en los informes de evaluación de medicamentos en la web del grupo GENESIS de la SEFH. Farm Hosp 2011 May-Jun;35(3):140-147

Resumen

An active comparator was present in 95% of the 337 analysed reports; 50% included a direct comparative study vs comparator. In 114 reports (34%), an IC was used; 69% of the ICs were made by the report author. Most ICs were narrative and none were adjusted. An IC could have been made in an additional 16% of the cases and possibly in 24% more. Conclusions: Most evaluated drugs have an active comparator but studies comparing them directly are not as common. ICs could be included in more reports along with quality control criteria. © 2011 SEFH. Published

URI :

https://hdl.handle.net/10171/22957

DOI:

http://dx.doi.org/10.1016/j.farma.2011.11.005

Aparece en las colecciones:

DA - CUN - Farmacología clínica - Artículos de revista
DA - Farmacia - Farmacia CUN - Artículos de revista

Ficheros en este ítem: